ClinOne – a leader in adaptive experiences for sites, participants, and their families – recently announced that it closed additional funding in its Series A financing to bring its total funding raised in this round to $5 million. The initial Series A funding round was announced back in April and was led by venture capital firm Boulder Ventures, with participation from existing investors. Boulder Ventures and Highpoint Ventures joined to extend the funding for this round.
ClinOne also announced the appointment of two accomplished life sciences leaders to its Board: Katherine Vandebelt and JeanMarie Markham, RN. Both will contribute extensive experience and strategic insights to support ClinOne’s vision.
Vandebelt is joining the ClinOne Board from her work as the Global Vice President of Clinical Innovation at Oracle Life Sciences. And she served as content expert and workstream leader for unprecedented collaborations with public health and government organizations to accelerate the development and distribution of COVID-19 vaccines, therapeutics, and diagnostic testing. Vandebelt enjoyed exploring the depths of innovation and human compassion in clinical research as host of the top-rated podcast The Latest Dose.
Vandebelt also served at Eli Lilly and Company, where she held various leadership positions in Clinical Operations, Statistical Sciences, Data Sciences and Solutions completing her 30-year career as Global Head of Clinical Innovation. Upon their retirement from Lilly, she served as Chief Ecosystem Officer at Reify Health where she generated their first Go to Market strategy for pharmaceutical customers and drove global product strategy.
JeanMarie Markham, RN, is an accomplished Life Science Executive, CEO & Founder with over 25 years of in-depth clinical research and international business experience. And JeanMarie founded Clinlogix, a Clinical Research Organization (CRO), with the goal of providing exceptional service and resources to researchers and founders in life science by assisting them in navigating global regulatory and clinical development pathways, meeting unmet medical needs of patients and improving quality of life and health.
JeanMarie founded Markham & Associates to offer Clinical Monitoring and Investigator Management services to the industry. And she developed an international platform of experienced Clinical Research Associates to provide clients with clinical monitoring services in multi-therapeutic areas. Concurrently, she also developed a platform of Clinical Investigators and clinical sites – one of the early Site Management Organizations (SMO). She was named to the 2007 PharmaVoice 100, 2019 Philadelphia Business Journal’s 12 Power Women in Life Sciences, and 2020 Healthcare CEO of the Year, PACT Enterprise Award.
KEY QUOTES:
“We are excited to partner with ClinOne and are impressed with the management team. We support ClinOne’s mission to transform the experiences of clinical sites and how they operate to more effectively to serve participants.”
— Jason Grimes, Co-Founder and Managing Director at Highpoint Ventures
“It’s an honor to join the ClinOne Board of Directors at this critical moment when the needs of clinical sites and participants are at a pivotal point. ClinOne is well-positioned to immediately address the challenge both with technology and innovative alternatives to rapidly change how site and participants engage in support of clinical research.”
— Katherine Vandebelt
“I’m thrilled to join the Board of Directors and lend my clinical and operational expertise as ClinOne continues to scale its comprehensive site hub and participant engagement platform.”
— JeanMarie Markham, RN
“We are very fortunate to have Katherine and JeanMarie join the ClinOne Board. Their enthusiasm, deep experience and thought leadership brings such richness to the ClinOne team. We are excited to collaborate with them to advance our mission so vital to empowering sites for clinical research and helping participants and their families live their best lives.”
— Andrea Valente, CEO at ClinOne
